1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cosmo Pharmaceuticals N.V.
  6. News
  7. Summary
    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
Delayed Swiss Exchange  -  11:30 2022-06-24 am EDT
46.00 CHF   -0.54%
06/21COSMO PHARMACEUTICALS N : June Investor Presentation
PU
06/01COSMO PHARMACEUTICALS N.V. : Ex-dividend day for final dividend
FA
05/27COSMO PHARMACEUTICALS N : ' Shareholders approve all Agenda Items at Annual General Meeting
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cosmo Pharmaceuticals, Medtronic Sign Global Distribution Deal for Eleview

05/03/2022 | 01:25am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
COSMO PHARMACEUTICALS N.V. -0.54% 46 Delayed Quote.-29.50%
MEDTRONIC PLC 1.75% 90.22 Delayed Quote.-12.79%
All news about COSMO PHARMACEUTICALS N.V.
06/21COSMO PHARMACEUTICALS N : June Investor Presentation
PU
06/01COSMO PHARMACEUTICALS N.V. : Ex-dividend day for final dividend
FA
05/27COSMO PHARMACEUTICALS N : ' Shareholders approve all Agenda Items at Annual General Meetin..
PU
05/27Cosmo Pharmaceuticals? Shareholders approve all Agenda Items at Annual General Meeting ..
EQ
05/25COSMO PHARMACEUTICALS N : May Investor Presentation
PU
05/03Cosmo Pharmaceuticals, Medtronic Sign Global Distribution Deal for Eleview
MT
05/03Cosmo announces expanding the agreement with medtronic for eleview(r) to all countries ..
EQ
05/03Cosmo Pharmaceuticals N.V. Announces Expanding the Agreement with Medtronic for Eleview..
CI
05/03COSMO PHARMACEUTICALS N : Announces expanding the agreement with medtronic for eleview® to..
PU
05/02COSMO PHARMACEUTICALS N : Notification of number of shares
PU
More news
Analyst Recommendations on COSMO PHARMACEUTICALS N.V.
More recommendations
Financials
Sales 2022 96,7 M 102 M 102 M
Net income 2022 16,8 M 17,7 M 17,7 M
Net cash 2022 41,8 M 44,1 M 44,1 M
P/E ratio 2022 45,9x
Yield 2022 1,31%
Capitalization 763 M 805 M 805 M
EV / Sales 2022 7,46x
EV / Sales 2023 5,13x
Nbr of Employees 290
Free-Float 48,0%
Chart COSMO PHARMACEUTICALS N.V.
Duration : Period :
Cosmo Pharmaceuticals N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMO PHARMACEUTICALS N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 45,68 €
Average target price 85,12 €
Spread / Average Target 86,3%
EPS Revisions
Managers and Directors
Alessandro Della Chà Executive Director
Niall Donnelly Chief Financial Officer
Mauro Severino Ajani Director
Davide Malavasi Director-Qualified Person & Technical
Nhan Ngo Dinh Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
COSMO PHARMACEUTICALS N.V.-29.50%766
JOHNSON & JOHNSON5.02%462 443
ELI LILLY AND COMPANY17.88%276 070
PFIZER, INC.-15.17%275 327
ABBVIE INC.12.51%260 755
ROCHE HOLDING AG-19.20%259 627